Editorial: Are we really greedy? FREE

Richard DiCicco

J Generic Med 4: 79-80; advance online publication, November 7, 2006; doi:10.1057/palgrave.jgm.4950052

Abstract | Full Text | PDF

Strike while the iron is hot: Changing the rules in essential health R&D is urgently needed, and is within reach

Ellen 't Hoen and James Arkinstall

J Generic Med 4: 81-86; advance online publication, November 28, 2006; doi:10.1057/palgrave.jgm.4950056

Abstract | Full Text | PDF

The CEE generics pharmaceutical sector: Ways to minimise cultural heritage barriers to mergers and acquisitions

Malcolm Ross and Malgorzata Lupina-Dziomdziora

J Generic Med 4: 117-126; advance online publication, November 7, 2006; doi:10.1057/palgrave.jgm.4950051

Abstract | Full Text | PDF

Alza v Mylan: A defence of 'Teaching, suggestion or motivation' and the unresolved question of inherent anticipation

Frederick H Rein and Amanda M Kessel

J Generic Med 4: 127-132; advance online publication, December 5, 2006; doi:10.1057/palgrave.jgm.4950055

Abstract | Full Text | PDF

Preliminary injunctions, regulatory approvals and parallel imports

Michael Burdon, Priya Vatvani and Oliver Ellington

J Generic Med 4: 133-141; advance online publication, December 19, 2006; doi:10.1057/palgrave.jgm.4950057

Abstract | Full Text | PDF

Takeda Chemical Industries Ltd v Mylan Laboratories, Inc: Award of attorneys' fees sends shock waves through the generic drug industry

Benjamin P Kota

J Generic Med 4: 142-147; advance online publication, November 28, 2006; doi:10.1057/palgrave.jgm.4950058

Abstract | Full Text | PDF

EU Legal and Regulatory Update

J Generic Med 4: 148-152; advance online publication, November 28, 2006; doi:10.1057/palgrave.jgm.4950053

Abstract | Full Text | PDF

The changing face of patents in generic pharmaceutical development: Facts and figures

Leighton Howard

J Generic Med 4: 153-157; advance online publication, November 28, 2006; doi:10.1057/palgrave.jgm.4950054

Abstract | Full Text | PDF